Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

NNNN

Anbio Biotechnology

$6.09Sep 28, 2026

AI confidence 50% · prior close shown (market closed)

Investment Snapshot

Limited proprietary earnings coverage for NNNN yet — signals will sharpen as filings and earnings are ingested.

Pipeline evidence · 79d ago

NNNN's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on NNNN.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest Intelligence

Updated

What happened recently for Anbio Biotechnology (NNNN) — events, not interpretation.

Event
Last session September 28, 2026 at $6.09.
Source
Market data

Research & analysis only — not investment advice.

Loading earnings intelligence…

Anbio Biotechnology (NNNN)

US equity research on AlphaOS

Investment Snapshot above is the primary AlphaOS analysis for Anbio Biotechnology — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Market cap:
$265.96M
Revenue:
$8.65M

NNNN earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Anbio Biotechnology through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.